Kang L - Search Results

1

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes.

Kang L, Tang X, Zhang J, Li M, Xu N, Qi W, Tan J, Lou X, Yu Z, Sun J, Wang Z, Dai H, Chen J, Lin G, Wu D, Yu L. Kang L, et al. Exp Hematol Oncol. 2020 Jun 8;9:11. doi: 10.1186/s40164-020-00166-2. eCollection 2020. Exp Hematol Oncol. 2020. PMID: 32523801 Free PMC article.

2

pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis.

Jia Z, Gong Y, Pi Y, Liu X, Gao L, Kang L, Wang J, Yang F, Tang J, Lu W, Li Q, Zhang W, Yan Z, Yu L. Jia Z, et al. Among authors: kang l. Mol Pharm. 2018 Jan 2;15(1):53-62. doi: 10.1021/acs.molpharmaceut.7b00709. Epub 2017 Dec 7. Mol Pharm. 2018. PMID: 29148802

3

Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells.

Zhao L, Li J, Liu Y, Kang L, Chen H, Jin Y, Zhao F, Feng J, Fang C, Zhu B, Ding S, Yu L, Wei Y, Zhou J. Zhao L, et al. Among authors: kang l. J Immunother. 2018 Feb/Mar;41(2):45-52. doi: 10.1097/CJI.0000000000000207. J Immunother. 2018. PMID: 29252915

4

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.

Qu C, Li Z, Kang L, Wang Y, Dai H, Yin J, Chen G, Zhu M, Yao L, Xu T, Tian X, Xu Y, Chen J, Zhu X, Yu L, Wu D, Tang X. Qu C, et al. Among authors: kang l. Bone Marrow Transplant. 2019 Jul;54(7):1138-1140. doi: 10.1038/s41409-018-0423-y. Epub 2019 Jan 10. Bone Marrow Transplant. 2019. PMID: 30631098 No abstract available.

5

Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cells.

Yang F, Zhang J, Zhang X, Tian M, Wang J, Kang L, Qiu H, Wu D. Yang F, et al. Among authors: kang l. Onco Targets Ther. 2019 Mar 25;12:2187-2191. doi: 10.2147/OTT.S189103. eCollection 2019. Onco Targets Ther. 2019. PMID: 30988623 Free PMC article.

6

Successful chimeric antigen receptor T cell therapy in a case of primary testicular diffuse large-B-cell lymphoma with central nervous system progression.

Ping N, Qu C, Bai L, Kang L, Chen X, Wu Q, Xia F, Yu L, Yao H, Wu D, Jin Z. Ping N, et al. Among authors: kang l. Leuk Lymphoma. 2019 Nov;60(11):2814-2816. doi: 10.1080/10428194.2019.1605507. Epub 2019 May 14. Leuk Lymphoma. 2019. PMID: 31088197 No abstract available.

7

Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden.

Qu C, Ping N, Kang L, Liu H, Qin S, Wu Q, Chen X, Zhou M, Xia F, Ye A, Kong D, Li C, Yu L, Wu D, Jin Z. Qu C, et al. Among authors: kang l. J Immunother. 2020 Jan;43(1):32-37. doi: 10.1097/CJI.0000000000000284. J Immunother. 2020. PMID: 31219975 Clinical Trial.

8

Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma.

Li C, Zhang Y, Zhang C, Chen J, Lou X, Chen X, Kang L, Xu N, Li M, Tan J, Sun X, Zhou J, Yang Z, Zong X, Wang P, Xu T, Qu C, Huang H, Jin Z, Yu L, Wu D. Li C, et al. Among authors: kang l. JCI Insight. 2019 Jul 23;5(17):e130195. doi: 10.1172/jci.insight.130195. JCI Insight. 2019. PMID: 31335321 Free PMC article.

9

[Allogeneic CAR-T for treatment of relapsed and/or refractory multiple myeloma: four cases report and literatures review].

Yan LZ, Shang JJ, Shi XL, Qu S, Kang LQ, Xu N, Chang WR, Yu L, Wu DP, Fu CC. Yan LZ, et al. Among authors: kang lq. Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):650-655. doi: 10.3760/cma.j.issn.0253-2727.2019.08.005. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31495131 Free PMC article. Review. Chinese.

10

Anti-CD19 chimeric antigen receptor T-cells induce durable remission in relapsed Philadelphia chromosome-positive ALL with T315I mutation.

Yang F, Yang X, Bao X, Kang L, Zhou L, Wu X, Tang X, Fu Z, Ma X, Sun A, Zhang J, Qiu H, Wu D. Yang F, et al. Among authors: kang l. Leuk Lymphoma. 2020 Feb;61(2):429-436. doi: 10.1080/10428194.2019.1663417. Epub 2019 Sep 12. Leuk Lymphoma. 2020. PMID: 31512942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,522 results

Search Page

Filters